Orian J M, Vasilopoulos K, Yoshida S, Kaye A H, Chow C W, Gonzales M F
Higginbotham Neuroscience Research Institute, Department of Surgery (R.M.H.), University of Melbourne, Parkville, Victoria.
Br J Cancer. 1992 Jul;66(1):106-12. doi: 10.1038/bjc.1992.225.
The expression of the c-erbB-1, c-myc, Ha/N-ras and c-fos oncogenes was investigated in 62 astrocytomas of low, intermediate and high grades by immunogold silver histochemistry. Elevated expression of c-erbB-1 was observed in 95%, 48% and 86% of low, intermediate and high grade tumours respectively, c-myc in 5%, 33% and 76% respectively, Ha/N-ras in 0, 43% and 71% respectively and c-fos in 55%, 48% and 52% respectively. Controls included normal brain and tumour sections immunoreacted with pre-immune serum or with antisera absorbed with synthetic peptides. Analysis of co-overexpression revealed that low grade tumours co-overexpressed a maximum of two of these genes, intermediate grade tumours a maximum of three of these genes, while co-overexpression of all four genes was observed in some high grade tumours. Co-overexpression of c-erbB-1 and c-fos was frequently observed in low grade astrocytomas and may be predictive of non-progression. On the other hand, there was a statistically significant increase in the number of tumours overexpressing Ha/N-ras or c-myc with increasing grade of tumour, suggesting that overexpression of these two oncogenes may be indicative of progression.
通过免疫金银组织化学法,对62例低级别、中级别和高级别星形细胞瘤中c-erbB-1、c-myc、Ha/N-ras和c-fos癌基因的表达进行了研究。分别在95%的低级别肿瘤、48%的中级别肿瘤和86%的高级别肿瘤中观察到c-erbB-1表达升高;c-myc分别在5%、33%和76%的肿瘤中表达升高;Ha/N-ras分别在0、43%和71%的肿瘤中表达升高;c-fos分别在55%、48%和52%的肿瘤中表达升高。对照包括用免疫前血清或用合成肽吸收的抗血清进行免疫反应的正常脑和肿瘤切片。对共过表达的分析显示,低级别肿瘤最多共过表达其中两个基因,中级别肿瘤最多共过表达其中三个基因,而在一些高级别肿瘤中观察到所有四个基因的共过表达。在低级别星形细胞瘤中经常观察到c-erbB-1和c-fos的共过表达,这可能预示着病情无进展。另一方面,随着肿瘤级别的增加,过表达Ha/N-ras或c-myc的肿瘤数量有统计学意义的增加,表明这两个癌基因的过表达可能预示着病情进展。